The expression of AKT1 increased in the aconitine arrhythmia group, while the expression of AKT1 was decreased by treatment with DHI and sotalol, a known antiarrhythmia drug (Figure 7(a)). The gene discussed is AKT1; the disease is cardiac arrhythmia.